News und Analysen

The healthcare sector underperformed broader equities in 2025, but that shouldn't deter investors. Many companies in the industry performed relatively well and appear to be solid buy-and-hold

A rising tide doesn't lift all boats. For example, a boat with gaping holes in its hull will sink regardless of how high the tide rises. Pfizer (NYSE: PFE) seemed to be the investing equivalent of

Shares of Super Micro Computer (NASDAQ: SMCI) sank 13.5% in December, according to data from S&P Global Market Intelligence. As an assembler of advanced computer chips for data center providers, the

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special

Over short periods, Wall Street is largely driven by emotions. When there's a compelling story, such as the emergence of GLP-1 weight loss drugs in the pharmaceutical sector, investors tend to

Did you know that in just the past three years, healthcare giant Pfizer (NYSE: PFE) has lost approximately half its value? The stock surged during the pandemic as its COVID-19 vaccine and pill

The beauty and wellness industry operates largely on an old-economy model in which manufacturers sell products wholesale to retailers that are then responsible for figuring out how best to sell

Alumis (NASDAQ:ALMS), which develops targeted therapies for immune-mediated diseases, closed Tuesday’s session at $16.23, up 95.31%. Trading volume reached 64.1 million shares, coming in about

Nektar Therapeutics (NASDAQ: NKTR) was a big winner in 2025. The clinical-stage biotech saw its shares soar on positive clinical developments. Let's give credit where credit is due. Nektar's

Thousands of stocks fly under most investors' radars, but that doesn't mean all of them are worthy of your attention. In an attempt to make it easier to narrow down the huge universe of stocks to

The average blue chip dividend stock's current yield is somewhere in the ballpark of 3% to 4%. Therefore, to see one paying out nearly 7% of its value is as suspicious as it is impressive.

When the

Dividend stocks can be a good strategy for investors seeking a reliable and potentially more predictable stream of passive income. Two companies with high dividend yields are the longtime automaker

In a challenging industry, Royal Caribbean Cruises (NYSE: RCL) has stood out for its exemplary returns for shareholders over the past five years. The first two articles in this three-part series

It might not seem like it, but the S&P 500 flirted with bear market territory earlier this year. It has rebounded nicely since, but it's always worth considering which stocks would be worth buying

Programs like Social Security aren't designed to replace workers' entire income once they reach retirement age. So, it's important for everyone to plan ahead and build a nest egg for their golden

How many profitable, large-cap healthcare companies pay a dividend yield of over 5%? Only one.

Pfizer (NYSE: PFE) checks off all the boxes. It's profitable, raking in earnings of over $9.4 billion

Is 2026 the year Pfizer (NYSE: PFE) finally turns things around? The company has been struggling over the past few years due to poor financial results and looming patent cliffs. However, it has also

The new year has just begun, and I'm starting a new investing journey on this first trading day of 2026. All year long, I'm planning to look at stocks that have escaped many investors' attention

According to a November 14, 2025 SEC filing, HighVista Strategies LLC initiated a new stake in Cidara Therapeutics (NASDAQ:CDTX), acquiring 70,904 shares worth $6.79 million as of September 30

While Ultragenyx Pharmaceutical (NASDAQ: RARE) provided the market with disappointing news yesterday -- shares plunged more than 42% -- it appears that investors aren't completely writing off the

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special